Makar Ralph 4
4 · BIOJECT MEDICAL TECHNOLOGIES INC · Filed Jan 2, 2009
Insider Transaction Report
Form 4
Makar Ralph
CEO/President
Transactions
- Exercise/Conversion
Restricted Stock Unit
2008-12-31−50,000→ 390,934 totalFrom: 2008-12-31→ BJCT Common Stock (50,000 underlying) - Exercise/Conversion
BJCT Common Stock
2008-12-31+50,000→ 295,701 total
Holdings
- 15,441(indirect: By 401(k))
BJCT Common Stock
Footnotes (4)
- [F1]1/3 vesting per Executive Employment Agreement date October 1, 2007.
- [F2]Each Restricted Stock Unit represents a contingent right to receive one share of BJCT Common Stock.
- [F3]No expiration date.
- [F4]Includes Series F Preferred Stock 67,600, Warrant (right-to-buy) 6,667, Option (right-to-buy) 150,000 Restricted Stock Unit 166,667.